937591-97-4 Usage
Uses
Used in Pharmaceutical Research:
1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-1-yl)ethanone is used as a building block for the synthesis of novel pharmaceutical compounds. Its unique structure facilitates the formation of essential carbon-carbon and carbon-heteroatom bonds, which are crucial for the development of new drugs and biologically active molecules.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-1-yl)ethanone serves as a key component for creating various organic molecules. Its ability to form carbon-carbon and carbon-heteroatom bonds makes it a versatile compound for constructing complex organic structures.
Used in Catalytic Processes:
The boron-containing group in 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-1-yl)ethanone makes it a useful catalyst in chemical reactions. It can enhance the efficiency and selectivity of various catalytic processes, further expanding its applications in synthetic chemistry and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 937591-97-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,7,5,9 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 937591-97:
(8*9)+(7*3)+(6*7)+(5*5)+(4*9)+(3*1)+(2*9)+(1*7)=224
224 % 10 = 4
So 937591-97-4 is a valid CAS Registry Number.
937591-97-4Relevant academic research and scientific papers
N-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS KINASE INHIBITORS
-
, (2014/09/03)
The present invention provides N-substituted novel heterocyclic derivatives of formula (I) as protein kinase inhibitors, in which R1, R2 and 'n' have the same meanings given in the specification, and pharmaceutically acceptable salts
NEW COMPOUNDS
-
Page/Page column 124, (2008/06/13)
This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
